Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirlande Duclos

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 5, 2018
In Reply to Azria et alSandrine Pereira, Larry Bodgi, Mirlande Duclos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and PerformanceSandrine Pereira, Larry Bodgi, Mirlande Duclos, et al.
Cancers|June 2, 2021
Proof of Concept of a Binary Blood Assay for Predicting RadiosensitivitySophie Deneuve, Céline Mirjolet, Thierry Bastogne, et al.
Tumori|September 15, 2025
Predicting severe toxicity after head-and-neck cancer RT: Validation of the synergist role of a biological marker and dosimetrySandrine Pereira, Tiziana Rancati, Nicola Alessandro Iacovelli, et al.
Tumori|May 17, 2022
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot studySophie Deneuve, Thierry Bastogne, Mirlande Duclos, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|May 5, 2018
In Reply to Azria et alSandrine Pereira, Larry Bodgi, Mirlande Duclos, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2018
Fast and Binary Assay for Predicting Radiosensitivity Based on the Theory of ATM Nucleo-Shuttling: Development, Validation, and PerformanceSandrine Pereira, Larry Bodgi, Mirlande Duclos, et al.
Cancers|June 2, 2021
Proof of Concept of a Binary Blood Assay for Predicting RadiosensitivitySophie Deneuve, Céline Mirjolet, Thierry Bastogne, et al.
Tumori|September 15, 2025
Predicting severe toxicity after head-and-neck cancer RT: Validation of the synergist role of a biological marker and dosimetrySandrine Pereira, Tiziana Rancati, Nicola Alessandro Iacovelli, et al.
Tumori|May 17, 2022
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot studySophie Deneuve, Thierry Bastogne, Mirlande Duclos, et al.
Pageof 1